Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emerging Biopharma
Biotech
GPCR firm Septerna files for IPO on strength of preclinical data
The GPCR specialist is asking investors to fund its lead hypoparathyroidism candidate through phase 2 before it shares initial data in humans.
Nick Paul Taylor
Oct 3, 2024 6:00am
Zephyrm seeks Hong Kong IPO to fund phase 3 cell therapy trials
Oct 2, 2024 8:19am
Kailera launches with $400M series A, 4 Chinese obesity drugs
Oct 1, 2024 8:30am
Arch closes $3B-plus fund to foster biopharma upstarts
Sep 26, 2024 10:24am
Flagship hopes biotechs flock to Mirai to boost genetic meds
Sep 26, 2024 6:00am
Aptadir hopes new RNA inhibitors can reverse tricky cancers
Sep 24, 2024 9:50am
More News
New cell therapy biotech emerges from the lab of George Church
Sep 19, 2024 6:30am
AAV gene therapy biotech unveils with 10 pipeline products
Sep 12, 2024 7:00am
Candid flashes big ambitions with $370M debut
Sep 9, 2024 9:00am
Medera plans SPAC merger to advance cardiac gene therapies
Sep 5, 2024 10:50am
See more stories
